You can find the annual or quarterly income statement of Silexion Therapeutics Corp here for insights into the performance and operational efficiency of Silexion Therapeutics Corp.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating expenses

131.89%4.41M

-59.03%3.29M

64.91%2.28M

32.00%1.65M

9.95%1.90M

999.32%8.04M

-2.05%1.39M

54.70%1.25M

254.02%1.73M

208.44%731.00K

800.67%1.41M

130.70%808.00K

--488.11K

--237.00K

--156.99K

--350.24K

R&D expenses

287.49%3.38M

-32.95%2.16M

32.90%1.02M

-38.61%590.00K

-30.71%871.00K

501.31%3.22M

-37.98%766.00K

41.12%961.00K

--1.26M

--535.00K

--1.23M

--681.00K

----

Depreciation, depletion, and amortization

--3.00K

-81.82%4.00K

-57.14%3.00K

-50.00%4.00K

----

120.00%22.00K

-50.00%7.00K

-46.67%8.00K

--6.00K

--10.00K

--14.00K

--15.00K

--0.00

Other operating expenses

----

---13.00K

----

Operating profit

-131.89%-4.41M

59.03%-3.29M

-64.91%-2.28M

-32.00%-1.65M

-9.95%-1.90M

-999.32%-8.04M

2.05%-1.39M

-54.70%-1.25M

-254.02%-1.73M

-208.44%-731.00K

-800.67%-1.41M

-130.70%-808.00K

---488.11K

---237.00K

---156.99K

---350.24K

Net non-operating interest income (expenses)

Non-operating interest income

--142.00K

----

-100.00%0.00

-84.62%6.00K

-51.28%19.00K

-96.68%33.00K

-91.92%42.00K

-76.12%39.00K

315.51%39.00K

--992.92K

--520.02K

--163.34K

--9.39K

Non-operating interest expense

204.17%73.00K

----

--24.00K

----

Gains from sale of securities

13.21%-46.00K

65.05%-36.00K

-38.64%-61.00K

102.83%3.00K

-148.18%-53.00K

9.65%-103.00K

91.08%-44.00K

-402.86%-106.00K

--110.00K

---114.00K

---493.00K

--35.00K

----

Special income (expenses)

-112.55%-29.00K

100.73%27.00K

-209.38%-198.00K

2.47%-79.00K

359.55%231.00K

---3.72M

-3300.00%-64.00K

-8200.00%-81.00K

-756.35%-89.00K

-100.00%0.00

-94.50%2.00K

-98.95%1.00K

---10.39K

--9.56K

--36.35K

--95.19K

Income before tax

-152.69%-4.41M

72.49%-3.26M

-68.12%-2.50M

-22.36%-1.73M

-4.30%-1.75M

-1376.71%-11.86M

20.31%-1.49M

-93.45%-1.42M

-438.58%-1.67M

-374.46%-803.00K

-4470.74%-1.87M

-198.38%-733.00K

--494.41K

--292.58K

--42.69K

---245.66K

Income tax

-100.00%0.00

50.00%3.00K

-100.00%0.00

-83.33%1.00K

-66.67%2.00K

-80.00%2.00K

-50.00%5.00K

--6.00K

--10.00K

----

Income after tax

-152.55%-4.41M

72.50%-3.26M

-68.10%-2.50M

-21.93%-1.73M

-3.99%-1.75M

-1366.01%-11.86M

20.63%-1.49M

-91.52%-1.42M

-439.80%-1.68M

-376.51%-809.00K

-4494.16%-1.88M

-202.45%-743.00K

--494.41K

--292.58K

--42.69K

---245.66K

Net income from continuous operations

-152.55%-4.41M

72.50%-3.26M

-68.10%-2.50M

-21.93%-1.73M

-3.99%-1.75M

-1366.01%-11.86M

20.63%-1.49M

-91.52%-1.42M

-439.80%-1.68M

-376.51%-809.00K

-4494.16%-1.88M

-202.45%-743.00K

--494.41K

--292.58K

--42.69K

---245.66K

Other net gains and losses

----

--4.00K

----

Net Income attributable to non-controlling interests

--0.00

-100.00%0.00

--0.00

----

--9.00K

----

Net income attributable to controlling interests

-152.55%-4.41M

72.50%-3.26M

-68.10%-2.50M

-21.93%-1.73M

-3.99%-1.75M

-1366.01%-11.86M

20.63%-1.49M

-91.52%-1.42M

-439.80%-1.68M

-376.51%-809.00K

-4494.16%-1.88M

-202.45%-743.00K

--494.41K

--292.58K

--42.69K

---245.66K

Net income attributable to common shareholders

-152.55%-4.41M

72.50%-3.26M

-68.10%-2.50M

-21.93%-1.73M

-3.99%-1.75M

-1366.01%-11.86M

20.63%-1.49M

-91.52%-1.42M

-439.80%-1.68M

-376.51%-809.00K

-4494.16%-1.88M

-202.45%-743.00K

--494.41K

--292.58K

--42.69K

---245.66K

Basic earnings per share

-48.39%-1.40

69.84%-2.88

-214.83%-4.32

80.48%-0.26

38.95%-0.94

-1180.87%-9.55

20.63%-1.37

-91.52%-1.31

-5001.27%-1.55

-3883.65%-0.75

-60324.74%-1.73

-4038.69%-0.68

--0.03

--0.02

--0.00

---0.02

Diluted earnings per share

-48.39%-1.40

69.84%-2.88

-214.83%-4.32

80.48%-0.26

38.95%-0.94

-1180.87%-9.55

20.63%-1.37

-91.52%-1.31

-5001.27%-1.55

-3883.65%-0.75

-60324.74%-1.73

-4038.69%-0.68

--0.03

--0.02

--0.00

---0.02

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

